as on October 31, 2025 at 1:29 am IST
Day's Low
Day's High
7.71%
Downside
3.28%
Upside
52 Week's Low
52 Week's High
26.41%
Downside
23.72%
Upside
Check Biogen Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$21.7B
EPS (TTM)
15.7618
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.08%
PE Ratio (TTM)
14.15
Industry PE ratio
19.200384615384614
PEG Ratio
6.2424
EBITDA
3.2B
Revenue (TTM)
10.0B
Profit Margin
15.31%
Return On Equity TTM
9.13%
Track how Biogen Inc. P/E has moved over time to understand its valuation trends.
Biogen Inc. in the last 5 years
Lowest (7.86x)
December 31, 2020
Today (14.15x)
October 30, 2025
Industry (19.20x)
October 30, 2025
Highest (18.33x)
June 30, 2023
Today’s Price to Earnings Ratio: 14.15x
Compare market cap, revenue, PE, and other key metrics of Biogen Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $21.7B | -41.34% | 14.15 | 15.31% | |
| BUY | $729.3B | 523.59% | 53.03 | 25.91% | |
| BUY | $402.0B | 164.56% | 108.87 | 6.45% | |
| BUY | $450.4B | 36.1% | 18.06 | 27.26% | |
| BUY | $229.6B | 60.81% | 13.41 | 35.61% |
The Biogen Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Biogen Inc. investment value today
Current value as on today
₹88,198
Returns
Returns from Biogen Inc. Stock
Dollar Returns*
₹5,667 (+5.67%)
Based on 42 analysts
71.43%
Buy
28.57%
Hold
0.00%
Sell
Based on 42 analysts, 71.43% of analysts recommend a 'BUY' rating for Biogen Inc.. Average target price of $172.55
Get share price movements and forecasts by analysts on Biogen Inc..
What analysts predicted
13.34%UPSIDE
Target Price
$172.55
Current Price
$149.53
Analyzed by
42 Analysts
Target
$172.55
Biogen Inc. target price $172.55, a slight upside of 13.34% compared to current price of $149.53. According to 42 analysts rating.
Search interest for Biogen Inc. Stock has decreased by -55% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Today's Timeline - 30 October
Thu, 06:16 PM
-Biogen reports Q3 results, beating revenue and EPS estimates but lowers full-year EPS guidance, causing a 4.2% stock drop.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
![]()
Netprofit is up for the last 2 quarters, 240.5M → 634.8M (in $), with an average increase of 62.1% per quarter
Price Rise
![]()
In the last 1 month, BIIB stock has moved up by 5.6%
Revenue Rich
![]()
Revenue is up for the last 2 quarters, 2.43B → 2.64B (in $), with an average increase of 8.1% per quarter
Against Peers
![]()
In the last 1 year, Johnson & Johnson has given 16.2% return, outperforming this stock by 34.6%
Against Peers
![]()
In the last 3 years, Eli Lilly And Company has given 6.7% return, outperforming this stock by 54.7%
| Organisation | Biogen Inc. |
| Headquarters | 225 Binney Street, Cambridge, MA, United States, 02142 |
| Industry | Health Technology |
| CEO | Mr. Christopher A. Viehbacher |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. Christopher A. Viehbacher | President, CEO & Director |
Ms. Nicole Murphy | Executive VP and Head of Pharmaceutical Operations & Technology |
Mr. Sean Godbout | Chief Accounting Officer & Global Corporate Controller |
Mr. Adam Keeney Ph.D. | Executive VP & Head of Corporate Development |
Dr. Ginger Gregory Ph.D. | Executive VP & Chief Human Resources Officer |
Ms. Susan H. Alexander Esq. | Executive VP & Chief Legal Officer |
Dr. Priya Singhal M.D., M.P.H. | Executive VP & Head of Development |
Ms. Robin C. Kramer | Executive VP & CFO |
Mr. Guy Hadari | Chief Information Officer |
Mr. Tim Power M.B.A., Ph.D. | Head of Investor Relations |
Biogen Inc. share price today is $149.53 as on at the close of the market. Biogen Inc. share today touched a day high of $154.44 and a low of $138.
Biogen Inc. share touched a 52 week high of $185 on and a 52 week low of $110.04 on . Biogen Inc. stock price today i.e. is closed at $149.53,which is 19.17% down from its 52 week high and 35.89% up from its 52 week low.
Biogen Inc. market capitalisation is $0.02T as on .
Indian investors can start investing in Biogen Inc. (BIIB) shares with as little as ₹88.686 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.86 in Biogen Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Biogen Inc. share’s latest price of $149.53 as on October 31, 2025 at 1:29 am IST, you will get 0.0669 shares of Biogen Inc.. Learn more about
fractional shares .
Biogen Inc. stock has given -41.34% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?